{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T12:31:03Z","timestamp":1783600263430,"version":"3.55.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":405,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Ministry of Science and Technology of China","award":["2010DFB30270"],"award-info":[{"award-number":["2010DFB30270"]}]},{"name":"Ministry of Science and Technology of China","award":["81172255"],"award-info":[{"award-number":["81172255"]}]},{"name":"Ministry of Science and Technology of China","award":["81101794"],"award-info":[{"award-number":["81101794"]}]},{"name":"National Natural Science Fund"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.bbmt.2013.11.022","type":"journal-article","created":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T14:00:42Z","timestamp":1385906442000},"page":"319-325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Secondary Monoclonal Gammopathy of Undetermined Significance Is Frequently Associated with High Response Rate and Superior Survival in Patients with Plasma Cell Dyscrasias"],"prefix":"10.1016","volume":"20","author":[{"given":"Dehui","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengxing","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhui","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenghuang","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lugui","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2013.11.022_bib1","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"Palumbo","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2013.11.022_bib2","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1182\/blood-2011-04-349175","article-title":"Incidence, clinical course, and prognosis of secondary monoclonal gammopathy of undetermined significance in patients with multiple myeloma","volume":"118","author":"Wadhera","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.11.022_bib3","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/bmt.2011.244","article-title":"Secondary MGUS after autologous hematopoietic progenitor cell transplantation in plasma cell myeloma: a matter of undetermined significance","volume":"47","author":"Manson","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.11.022_bib4","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1365-2141.2008.07374.x","article-title":"Atypical serum immunofixation patterns frequently emerge in immunomodulatory therapy and are associated with a high degree of response in multiple myeloma","volume":"143","author":"Mark","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2013.11.022_bib5","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group","volume":"121","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2013.11.022_bib6","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1182\/blood-2006-08-040410","article-title":"Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome","volume":"109","author":"Avet-Loiseau","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.11.022_bib7","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1182\/blood-2006-03-009910","article-title":"Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation","volume":"108","author":"Hanamura","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.11.022_bib8","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.3324\/haematol.2011.056176","article-title":"Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders","volume":"97","author":"Ross","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2013.11.022_bib9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3109\/10428194.2012.704033","article-title":"Further stratification of patients with multiple myeloma by International Staging System in combination with ratio of serum free kappa to lambda light chains","volume":"54","author":"Xu","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bbmt.2013.11.022_bib10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/sj.leu.2405016","article-title":"Clinically relevant end points and new drug approvals for myeloma","volume":"22","author":"Anderson","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2013.11.022_bib11","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/hon.936","article-title":"Abnormal protein bands in patients with multiple myeloma after haematopoietic stem cell transplantation: does it have a prognostic significance?","volume":"28","author":"Sucak","year":"2010","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.bbmt.2013.11.022_bib12","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1515\/CCLM.2010.050","article-title":"Oligoclonal bands and immunoglobulin isotype switch during monitoring of patients with multiple myeloma and autologous hematopoietic cell transplantation: a 16-year experience","volume":"48","author":"Alejandre","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.bbmt.2013.11.022_bib13","first-page":"113","article-title":"Significance of abnormal protein bands in patients with multiple myeloma following autologous stem cell transplantation","volume":"30","author":"Hall","year":"2009","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.bbmt.2013.11.022_bib14","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1182\/blood.V91.9.3518","article-title":"Oligoclonal protein bands and Ig isotype switching in multiple myeloma treated with high-dose therapy and hematopoietic cell transplantation","volume":"91","author":"Zent","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.11.022_bib15","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/TP.0b013e318225db2c","article-title":"Monoclonal gammopathy of undetermined significance does not affect outcomes in patients undergoing solid organ transplants","volume":"92","author":"Jimenez-Zepeda","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2013.11.022_bib16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3324\/haematol.2010.030882","article-title":"Emergence of oligoclonal bands in patients with multiple myeloma in complete remission after induction chemotherapy: association with the use of novel agents","volume":"96","author":"Fernandez de Larrea","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2013.11.022_bib17","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3324\/haematol.2013.084350","article-title":"Natural history and prognostic impact of oligoclonal humoral response in patients with multiple myeloma after autologous stem cell transplantation: long-term results from a single institution","volume":"98","author":"Tovar","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2013.11.022_bib18","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1182\/blood-2009-03-201053","article-title":"The role of complete response in multiple myeloma","volume":"114","author":"Harousseau","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.11.022_bib19","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/sj.leu.2404284","article-title":"International uniform response criteria for multiple myeloma","volume":"20","author":"Durie","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2013.11.022_bib20","doi-asserted-by":"crossref","first-page":"4954","DOI":"10.1182\/blood-2009-06-224832","article-title":"Abnormal serum free light chain ratio in patients with multiple myeloma in complete remission has strong association with the presence of oligoclonal bands: implications for stringent complete remission definition","volume":"114","author":"de Larrea","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.11.022_bib21","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1515\/cclm-2011-0544","article-title":"Serum free light chains and oligoclonal bands in patients with multiple myeloma and autologous stem cell transplantation","volume":"50","author":"Alejandre","year":"2012","journal-title":"Clin Chem Lab Med"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879113005594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879113005594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:46:59Z","timestamp":1761058019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879113005594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S1083879113005594"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2013.11.022","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Secondary Monoclonal Gammopathy of Undetermined Significance Is Frequently Associated with High Response Rate and Superior Survival in Patients with Plasma Cell Dyscrasias","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2013.11.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}